View Older Stories View More Recent Stories
-
BMO Named One of the 2018 World's Most Ethical Companies by the Ethisphere Institute
-
Aeglea Biotherapeutics (AGLE) PT Lowered to $18 at BMO Capital
-
Bank fee potential slashed as Trump ends Broadcom's Qualcomm takeover
-
Gateway Casinos Announces Successful Refinancing
-
UPDATE: BMO Capital Upgrades Centennial Resource Development (CDEV) to Outperform
-
UPDATE: BMO Capital Downgrades Wildhorse Resource Development (WRD) to Market Perform
-
General Moly Reports Fourth Quarter and 2017 Results
-
Amphastar Pharmaceuticals (AMPH) PT Raised to $19 at BMO Capital
-
BMO Financial Group Proxy Circular Now Available
-
BMO Financial Group Proxy Circular Now Available
-
BioXcel Therapeutics Announces Closing of Initial Public Offering
-
BioXcel Therapeutics Announces Closing of Initial Public Offering
-
Pre-Open Movers 03/12: (OCLR) (ADMS) (MU) Higher; (ANTH) (SVRA) (ESPR) Lower (more...)
-
Party City (PRTY) PT Raised to $20 at BMO Capital on 4Q Report; 'Better Visibility into Sales/Earnings Stream'
-
Kroger (KR) PT Lowered to $27 at BMO Capital
-
Broadcom Limited (AVGO) PT Raised to $345 at BMO Capital
-
BMO Capital Upgrades Century Aluminum (CENX) to Outperform, 'Higher Volume & Price = Compelling Math'
-
Canadian economy adds jobs in February, but full-time positions shrink
-
Flexion Therapeutics (FLXN) PT Lowered to $36 at BMO Capital
-
Casey's General Stores (CASY) PT Lowered to $105 at BMO Capital
-
Cooper Companies (COO) PT Raised to $280 at BMO Capital; 'This Looks Like Another Beat and Raise Year'
-
Chuy's Holdings (CHUY) PT Lowered to $27 at BMO Capital
-
MyoKardia (MYOK) PT Raised to $83 at BMO Capital
-
Gateway Casinos & Entertainment Announces Successful Consent Solicitation with Respect to 8.250% Second Priority Senior Secured Notes Due 2024
-
STORE Capital Announces Pricing of $350 Million Public Offering of 4.50% Senior Notes Due 2028
-
Successful completion of A$150m underwritten placement
-
Comtech Telecom (CMTL) PT Raised to $35 at BMO Capital on 2Q Report; 'Backlog Reached Near-Record Levels'
-
BioXcel Therapeutics (BTAI) IPO Opens Flat
-
H&R Block (HRB) PT Raised to $32 at BMO Capital
-
Canada housing starts, building permits rise on condo strength
-
BioXcel Therapeutics Announces Pricing of Initial Public Offering
-
Victoria Gold Announces Comprehensive C$500 Million Financing Package for Eagle and Continuation of Construction Activities
-
Regulus Therapeutics (RGLS) PT Raised to $1.37 at BMO Capital, Sees Shares 'Range-Bound'
-
Protagonist Therapeutics (PTGX) PT Trimmed to $42 at BMO Capital, But Sees Catalyst-Rich 2018
-
BMO Celebrates International Women's Day 2018 Highlighting Female Leadership
-
Dividend Select 15 Corp. Announces Successful Overnight Offering
-
BMO Capital Downgrades International Paper (IP) to Market Perform
-
BMO Capital Downgrades Carvana (CVNA) to Market Perform
-
Comerica (CMA) PT Raised to $116 at BMO Capital
-
Middleby Corp (MIDD) PT Raised to $160 at BMO Capital; 'All the Ingredients for a Top Pick'
-
Urban Outfitters, Inc. (URBN) PT Raised to $37 at BMO Capital
-
CIENA (CIEN) PT Raised to $32 at BMO Capital
-
Dividend Select 15 Corp. Announces Overnight Offering
-
Q2 Holdings Announces Jonathan Price as SVP of Corporate Development
-
Macquarie Capital Appoints Katan D’Souza to Further Expand TMT Group
-
Cross Country Healthcare (CCRN) PT Lowered to $13 at BMO Capital
-
Fate Therapeutics (FATE) PT Raised to $20 at BMO Capital; 'Enthusiasm for Cell Therapies Probably Justified'
-
BMO Capital Starts Becton Dickinson (BDX) at Market Perform
-
BMO Capital Starts Insulet Corporation (PODD) at Outperform
-
BMO Capital Starts iRhythm Technologies (IRTC) at Outperform

